Orthofix Medical Inc. Common Stock (DE) earnings per share and revenue
On Nov 04, 2025, OFIX reported earnings of -0.56 USD per share (EPS) for Q3 25, missing the estimate of -0.41 USD, resulting in a -37.42% surprise. Revenue reached 205.63 million, compared to an expected 204.01 million, with a 0.80% difference. The market reacted with a -7.41% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -0.31 USD, with revenue projected to reach 223.09 million USD, implying an decrease of -44.64% EPS, and increase of 8.49% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Orthofix Medical Inc. Common Stock (DE)'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Orthofix Medical Inc. Common Stock (DE) reported EPS of -$0.56, missing estimates by -37.42%, and revenue of $205.63M, 0.8% above expectations.
How did the market react to Orthofix Medical Inc. Common Stock (DE)'s Q3 2025 earnings?
The stock price moved down -7.41%, changed from $16.06 before the earnings release to $14.87 the day after.
When is Orthofix Medical Inc. Common Stock (DE) expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Orthofix Medical Inc. Common Stock (DE)'s next earnings report?
Based on 5
analysts, Orthofix Medical Inc. Common Stock (DE) is expected to report EPS of -$0.31 and revenue of $223.09M for Q4 2025.